ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1927

Heterogeneity of Juvenile Idiopathic Arthritis Synovial Fibroblasts Correlates to Disease Progression and Provides Compelling Diagnostic Data

Megan Simonds1, Kathleen Sullivan2, Carlos Rose3 and AnneMarie Brescia4, 1Nemours, Wilmington, DE, 2The Children's Hospital of Philadelphia, Philadelphia, PA, 3Thomas Jefferson University/duPont Hospital for Children, Wilmington, DE, 4Nemours/A.I.duPont Hospital for Children, Wilmington, DE

Meeting: ACR Convergence 2021

Keywords: chondrocyte, Fibroblasts, Synovial, genomics, Juvenile idiopathic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Abstracts: Pediatric Rheumatology – Basic Science (1927–1930)

Session Type: Abstract Session

Session Time: 3:30PM-3:45PM

Background/Purpose: Juvenile Idiopathic Arthritis (JIA) induces growth disturbances in affected joints. Fibroblast-like synoviocytes (FLS) play a crucial role in JIA pathogenesis; however, the mechanisms by which they contribute to disease progression is not well described. Previous studies demonstrated that rheumatoid arthritis (RA) FLS are heterogeneous, and subpopulations with transformed, aggressive phenotypes cause invasive and destructive disease activity (1). Here, we employ single-cell RNA sequencing (scRNA-seq) to investigate JIA FLS heterogeneity and its’ influence on disease extension.

Methods: JIA FLS cell lines from oligoarticular (oligo), extended-to-be (ETB), and polyarticular (poly) types were cultured. scRNA-seq was performed by Genewiz according to 10x Genomics Chromium protocols. Cell ranger software aggregated data from each patient to compare single-cell gene expressions within each JIA type. SeuratR package was used for QC, analysis, and exploration of data.

Results: Using t-Distributed Stochastic Neighbor Embedding (t-SNE), distinct clusters within each JIA FLS type illustrated heterogeneity (Figure 1A). Cells with similar expression patterns cluster together as indicated by a single color. Clusters in close proximity have similar gene expression profiles. Seurat performed Uniform Manifold Approximation and Projection (UMAP) dimensionality reduction, and the clusters co-localized. Majority of clusters within each type co-localize with greater distance between clusters within ETB and poly (Figure 1B). Cells were annotated based on similarity to a reference dataset of cells with known labels (Human Primary Cell Atlas Data) using SingleR data package. Subpopulation percentages were calculated from cell counts (Figure 2). Smooth muscle cell-like cells decreased in more severe JIA types (p< 0.05 in oligo v poly). Fibroblast-like cell percentage was higher in ETB than oligo (p< 0.05). Chondrocyte-like cells percentage increased in poly compared to oligo and ETB (p< 0.05). Differentially expressed genes were revealed within cell-type subpopulations between subtypes of JIA (Table 1). Specifically, ETB downregulate COL1A1 and ACAN and upregulate IFI27 and SERPINE1 in FLS-like cells when compared to oligo (p< 0.00). COL3A1 and VCAM were upregulated in chondrocyte-like cells in ETB when compared to oligo (p< 0.00).

Conclusion: Heterogeneity of FLS from JIA patients could present a novel JIA diagnostic tool. While single cells still co-localize by UMAP, known cell types were identified including: smooth muscle cell-like, fibroblast-like, and chondrocyte-like subpopulations. Differences in subpopulations composition in conjunction with differentially expressed genes within a subpopulation can contribute to distinguishing between subtypes of JIA. Specifically, predicting whether a patient will extend will allow clinicians to better determine therapeutic intervention.

1. Mizoguchi F, Slowikowski K, Wei K, Marshall JL, Rao DA, Chang SK, et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nature Communications. 2018;9(1):789.

t-SNE (A) and UMAP (B) of FLS from patients with oligoarticular JIA who stayed persistent course (top row) or went on to an extended course (ETB, middle row) or with polyarticular JIA.

Percentage of FLS subpopulations in cultured FLS from patients with oligoarticular (Oligo), ETB, and polyarticular (Poly) JIA. Smooth muscle-like cells decrease in more severe subtypes of JIA. Percentage of fibroblast-like cells significantly increases in ETB compared to Oligo.

Seurat single analysis identified the top features or genes of each projected cell type for each subtype. The dot plot shows the average expression of each feature in each cell type and the percent of cells that express that feature.


Disclosures: M. Simonds, None; K. Sullivan, None; C. Rose, None; A. Brescia, None.

To cite this abstract in AMA style:

Simonds M, Sullivan K, Rose C, Brescia A. Heterogeneity of Juvenile Idiopathic Arthritis Synovial Fibroblasts Correlates to Disease Progression and Provides Compelling Diagnostic Data [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/heterogeneity-of-juvenile-idiopathic-arthritis-synovial-fibroblasts-correlates-to-disease-progression-and-provides-compelling-diagnostic-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/heterogeneity-of-juvenile-idiopathic-arthritis-synovial-fibroblasts-correlates-to-disease-progression-and-provides-compelling-diagnostic-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology